Barclays
INSP icon

Barclays’s Inspire Medical Systems INSP Stock Holding History

Barclays’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,700
Closed -$1.77M – 5268
2021
Q4 		$1.77M Buy
+7,700
New +$1.88M ﹤0.01% 2461

Other funds holding INSP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Barclays's INSP Position: Q3 2026 in Review

Barclays reduced its Inspire Medical Systems (INSP) stake by 91% in Q3 2026, selling an estimated $16.7M and leaving 27,468 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

Barclays first reported a position in INSP in Q2 2018 and has held it in 34 quarters since. The position peaked at $15.9M in Q3 2023. 149 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Barclays held 27,468 shares of Inspire Medical Systems worth $1.91M as of Q3 2026.
  • Barclays sold 279,802 Inspire Medical Systems shares in Q3 2026, an estimated $16.7M.
  • Inspire Medical Systems made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2628 holding.
  • Barclays first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 34 quarters since.
  • Barclays's Inspire Medical Systems position peaked at $15.9M in Q3 2023.
  • 149 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.